Unknown PHASE4 INTERVENTIONAL 4-arm NCT02232971

Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes (GluST1)

Treatment of Hypoglycemia With Glucagon Among Patients With Type 1 Diabetes Mellitus

Sponsor: Hvidovre University Hospital

Interventions Glucagon Isotonic saline solution

Updated 6 times since 2017 Last updated: Mar 24, 2015 Started: Sep 30, 2014 Primary completion: Jan 31, 2015 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02232971, this PHASE4 trial focuses on Diabetes Mellitus, Type 1 and remains ongoing. Sponsored by Hvidovre University Hospital, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
May 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Active Not Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hvidovre University Hospital
The Novo Nordic Foundation
University of Copenhagen

Data source: Hvidovre University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hvidovre, Denmark